Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HyperHAES for ICP in SAH
NCT00199706Phase 2Completed
- Sponsor
- Oslo University Hospital
- Start
- Apr 2002
- Modality
- Polymer-based Nanoparticles, Small Molecules
01
Overview
A Phase 2 trial of HyperHAES in subarachnoid hemorrhage (SAH), sponsored by Oslo University Hospital. Started Apr 2002; status: completed.
02
Drugs
HyperHAES
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT00199706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00199706.